Breaking news | Tianjiquan Group has been awarded the 2022 Shenzhen "Specialized, Refined, Unique and New" Enterprise Certification
On March 15, 2023, the Shenzhen Small and Medium sized Enterprise Service Bureau announced the list of "Specialized, Refined, Unique and New" small and medium-sized enterprises in Shenzhen for the year 2022. After layers of expert review and comprehensive evaluation, Tianjiquan Group successfully won the recognition of "Specialized, Refined, Unique and New" small and medium-sized enterprises in Shenzhen with its innovative advantages and technological strength in quantum medical technology.
Public List of Specialized, Refined, Unique and New Small and Medium sized Enterprises in Shenzhen in 2022
The recognition of Tianjiquan Group as a specialized and innovative small and medium-sized enterprise in Shenzhen is not only a strong affirmation of Tianjiquan Group's product strength, innovation capability, patent achievements, R&D investment, growth indicators, talent structure and other aspects by the country, but also an incentive and impetus for the company's innovative development path. It marks a new level of development for Tianjiquan Group in quantum medical technology, fully demonstrating its huge advantages in specialization, innovation capability and development potential.
Shenzhen's specialized, refined, distinctive, and innovative small and medium-sized enterprises refer to those whose main business and development focus comply with national industrial policies and relevant requirements, with obvious characteristics of specialization, refinement, specialization, and novelty, strong innovation ability, fast development speed, high operational quality, strong financing ability, and good economic benefits. They are excellent representatives of the small and medium-sized enterprise group and an important force in promoting economic and social development.
As early as 2011, the Ministry of Industry and Information Technology proposed the concept of "specialization, refinement, uniqueness, and novelty" as an important evaluation criterion for the transformation and upgrading of small and medium-sized enterprises, and made strict requirements for the application conditions from multiple aspects such as key areas, degree of specialization, and innovation ability. The 2021 Politburo meeting elevated the development of specialized, refined, unique, and new small and medium-sized enterprises to a national level for the first time.
Since its establishment in 2001, Tianjiquan Group, under the leadership of Chairman and President Shi Yanbao, has focused on cutting-edge technology research, attached great importance to technological innovation and product development, and completed the research and development of multiple new products and patents. For over 20 years, Tianjiquan Group has continuously integrated its advantageous resources and cultivated and introduced a group of outstanding researchers, adhering to technological innovation. With products such as QRS quantum resonance health information detector and G SLT semiconductor laser therapy device, Tianjiquan Group has become a leader in the field of green health and a preferred brand for consumer healthcare and medical care.
Innovation is the primary driving force behind development, and it is also the soul of 'specialization, refinement, novelty'. Tianjiquan has independent research and development production bases to provide guarantees for technology research and product testing. We adhere to using innovative technology to create "specialized, refined, unique and new" health products. We have developed multiple health technology products that have successfully obtained patent product registration from the State Intellectual Property Office of the State Council, been listed on the Shenzhen government procurement platform, and selected for the "2022 Elderly Products Promotion Catalogue" by the Ministry of Industry and Information Technology. In addition, with our high-precision technology, Tianjiquan Group has also obtained multiple honorary titles such as "EU CE Certification", "Medical Device Import License" from South Korea, "National High tech Enterprise", "China's Most Influential Innovation Achievement Award", "South Africa Outstanding Scientific and Technological Achievement Award", and "Thailand Inventor's Day China Good Technology Exhibition Gold Award". In 2010 and 2011, Tianjiquan Group has won many honorary titles. Received the Excellent Product Award at multiple High Tech Fairs, including in 2012.
As a member of the "specialized, refined, unique, and innovative" enterprise, in the future, Tianjiquan Group will adhere to the guidance of "independent innovation" and continue to deepen its cultivation in specialization, refinement, specialization, novelty, and other aspects. It will continue to increase the innovation of quantum medical technology, continuously improve the level of medical and health services, consolidate its core competitiveness, help the big health industry achieve high-quality development, realize the Tianjiquan dream of making all mankind healthy as soon as possible, and create greater value for society.